"Setting Realistic Asthma Treatment Goals Across Diverse Patient Populations" features a candid exchange about how practice setting shapes what clinicians can realistically aim for.

In "Generic SGLT2 Inhibitors and Interpreting Divergent CKD Trial Data," Dr. Haumschild turns to generic tiering strategy and ...

Tennessee Oncology's Wade Iams, MD, MSCI, discusses staffing and tocilizumab access as barriers to expanding BiTE therapy and ...

ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports ...

Diagnostic delays in narcolepsy and idiopathic hypersomnia (IH) persist largely because of low awareness among patients, ...

Welcome back to another AJMC Stakeholder Summit series. In "Vitiligo Prevalence and Why It Isn't Cosmetic," moderator Susan ...

FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase ...

Nearly 3 in 4 adults undergoing metabolic bariatric surgery (MBS) at 4 international centers met criteria for clinical ...

Limited access to care means safety-net ICUs see advanced disease and poorer outcomes, while bias and social media add new ...

Pulmonologists play a key role in comprehensive biomarker testing, helping more patients with lung cancer access precise ...

The National Community Oncology Dispensing Association, Inc. (NCODA) is a grassroots, not-for-profit organization, founded to strengthen oncology organizations with medically integrated dispensing ...

OneOncology's Larry Bilbrey explains how to guide practices on AI without endorsing products and why technology gaps outweigh ...